Drug Approval | February 08, 2022
Lupin receives approval from USFDA for Arformoterol Tartrate inhalation
Arformoterol Tartrate had estimated annual sales of US $ 251 million in the U.S. (IQVIA MAT December 2021)
Arformoterol Tartrate had estimated annual sales of US $ 251 million in the U.S. (IQVIA MAT December 2021)
Soft-mist inhalation (SMI) technology allows for delivery of inhalation drugs from a small, portable hand-held inhaler device without the use of propellants
ALASTIN’s patented, differentiated technology and products are highly synergistic with Galderma’s premium portfolio
The ANDA has been co-developed in partnership with Orbicular Pharmaceutical Technologies
It’s the company’s fourth manufacturing site worldwide. Others are located in the US, UK and China
ABB Drives play a key role in the cleanroom infrastructure of Bharat Biotech, India’s first indigenous Covid-19 vaccine manufacturer. The drives are easy to commission, use and ensure higher energy efficiency
The Stasis connected care monitoring system includes - a bedside monitor that monitors 6 vital signs, a tablet that enables intuitive monitoring, and the Stasis app that allows for remote monitoring across devices
Arformoterol Tartrate Inhalation Solution, 15 mcg/2 mL, Unit-Dose Vials will be manufactured in the company’s North American manufacturing facility based in Monroe, North Carolina
Nanoform and Celanese intend to work on formulation development, leveraging each organization's unique formulation expertise.
Exemestane is a key therapeutic used in the treatment of certain types of breast cancer in postmenopausal women
Subscribe To Our Newsletter & Stay Updated
